4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-033638
Chief Executive Officer sold 5,850 shares at an average $23.09 ($135,089)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-05-29 | Sale | −2,200 | $22.85 | $50,270 | 294,337 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-05-29 | Sale | −725 | $23.30 | $16,893 | 293,612 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-05-30 | Sale | −1,425 | $22.72 | $32,376 | 292,187 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-05-30 | Sale | −1,500 | $23.70 | $35,550 | 290,687 | I: show line 4 in the form |
| Open-market sales · 5,850 sh · avg $23.09 · $135,089 | |||||||
Loading xslF345X03/doc4.xml…